Maura Camozzi

Title: Maura Camozzi: Innovator in FGF-Binding Peptides

Introduction

Maura Camozzi is a notable inventor based in Telgate, Italy. She has made significant contributions to the field of biotechnology, particularly in the development of peptides that interact with fibroblast growth factors (FGFs). Her innovative work has implications for therapeutic applications, especially in the context of angiogenesis.

Latest Patents

Maura Camozzi holds a patent for "FGF2-binding peptides and uses thereof." This patent describes synthetic peptides designed from the N-terminal region of PTX, specifically spanning the PTX(-O) region. These peptides are capable of binding to FGF and inhibiting its pro-angiogenic activity both in vitro and in vivo, without adversely affecting innate immunity. She has 1 patent to her name.

Career Highlights

Maura Camozzi is currently employed at Tecnogen S.p.a., where she continues her research and development efforts. Her work at Tecnogen has positioned her as a key player in the biotechnology sector, focusing on innovative solutions that address critical health challenges.

Collaborations

Maura collaborates with esteemed colleagues, including Marco Presta and Marco Rusnati. Their combined expertise enhances the research and development initiatives at Tecnogen, fostering an environment of innovation and discovery.

Conclusion

Maura Camozzi's contributions to the field of biotechnology, particularly through her work on FGF-binding peptides, highlight her role as an influential inventor. Her ongoing research promises to advance therapeutic strategies in the medical field.